A Cohort Study on Biomarkers of Hypertension in Guangdong Province(GDP Study)
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Non-interventional study.
- Who it may be relevant to
- Registry conditions: Hypertension, Cardiovascular Diseases. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- China
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Establishing Biobank in a Cohort Study for Hypertensive Patients in Guangdong Province(GDP Study)
Overview
Hypertension is the most common chronic diseases and a most important risk factor for cardiovascular and cerebrovascular diseases, and also a substantial public health problem. The purpose of the study is to investigate the association between biomarkers and adverse outcomes in patients with hypertension.
Detailed description
Study population includes subjects who are hypertension, of any race or ethnicity, 18 or older years of age, and have provided written informed consent to provide whole blood specimens at one or more study visits.
Physical examination, questionnaire survey and biological sample collection will be conducted at baseline and the incidence of all-cause and cardiovascular mortality will be investigated during follow-up.
Interventions
- Other Non-interventional study
This is an observational, non-interventional study
Primary outcome measures
- All-Cause Mortality [Time frame: From date of inclusion until the date of death from any cause, assessed up to 1 year]
Secondary outcome measures (1)
- Cardiovascular Mortality [Time frame: From date of inclusion until the date of death from any cause, assessed up to 1 year]
Eligibility criteria
Inclusion criteria
- ≥18 years old
- In accordance with the diagnosis of hypertension (including Blood pressure ≥140/90mmHg and/or taking antihypertensive drugs and/or self-reported hypertension)
Exclusion criteria
- <18 years old
- Unsigned informed consent
- Pregnant Women and Lactation
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
China · 2 centers
- Guangdong Provincial People's Hospital — Guangzhou
- Guangdong Cardiovascular Institute — Guangzhou
Identifiers
NCT: NCT04212455 · 2019343H(R2)